DE60134342D1 - Verfahren zur untersuchung der fähigkeit zur kontrolle der nervenzellplastizität - Google Patents

Verfahren zur untersuchung der fähigkeit zur kontrolle der nervenzellplastizität

Info

Publication number
DE60134342D1
DE60134342D1 DE60134342T DE60134342T DE60134342D1 DE 60134342 D1 DE60134342 D1 DE 60134342D1 DE 60134342 T DE60134342 T DE 60134342T DE 60134342 T DE60134342 T DE 60134342T DE 60134342 D1 DE60134342 D1 DE 60134342D1
Authority
DE
Germany
Prior art keywords
ability
amino acid
regulatory factor
transcription regulatory
examining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60134342T
Other languages
English (en)
Inventor
Norihisa Ohe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Application granted granted Critical
Publication of DE60134342D1 publication Critical patent/DE60134342D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE60134342T 2000-12-27 2001-12-17 Verfahren zur untersuchung der fähigkeit zur kontrolle der nervenzellplastizität Expired - Lifetime DE60134342D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000398548 2000-12-27
JP2001077740 2001-03-19
PCT/JP2001/011063 WO2002053736A1 (fr) 2000-12-27 2001-12-17 Methode d'examen de la capacite a controler la plasticite des cellules nerveuses

Publications (1)

Publication Number Publication Date
DE60134342D1 true DE60134342D1 (de) 2008-07-17

Family

ID=26606895

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60133774T Expired - Lifetime DE60133774T2 (de) 2000-12-27 2001-12-17 Transkriptionsaktivierungskomplex und dessen verwendung
DE60134342T Expired - Lifetime DE60134342D1 (de) 2000-12-27 2001-12-17 Verfahren zur untersuchung der fähigkeit zur kontrolle der nervenzellplastizität

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60133774T Expired - Lifetime DE60133774T2 (de) 2000-12-27 2001-12-17 Transkriptionsaktivierungskomplex und dessen verwendung

Country Status (6)

Country Link
US (3) US20040110171A1 (de)
EP (3) EP1354946B1 (de)
AT (3) ATE397664T1 (de)
CA (3) CA2433501C (de)
DE (2) DE60133774T2 (de)
WO (3) WO2002053735A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030190653A1 (en) * 2002-01-11 2003-10-09 Mehrdad Shamloo Regulated gene in the pathophysiology of ischemic stroke
US7618947B2 (en) 2004-08-25 2009-11-17 Isis Pharmaceuticals, Inc. Modulation of HIF-1 beta expression
JP2007282502A (ja) * 2006-03-24 2007-11-01 Sumitomo Chemical Co Ltd 細胞変性制御能力の検定方法
JP2007282501A (ja) * 2006-03-24 2007-11-01 Sumitomo Chemical Co Ltd アポトーシス制御能力の検定方法
US11889986B2 (en) 2010-12-09 2024-02-06 Endochoice, Inc. Flexible electronic circuit board for a multi-camera endoscope

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757524B1 (fr) * 1996-12-19 1999-01-29 Rhone Poulenc Rorer Sa Polypeptides de la famille bhlh, sequences d'acides nucleiques correspondantes
US5840532A (en) 1997-01-21 1998-11-24 Board Of Regents, The University Of Texas System Neuronal bHLH-PAS domain proteins
US7105647B1 (en) 1997-11-28 2006-09-12 Wisconsin Alumni Research Foundation cDNAs and proteins involved in hypoxia, circadian and orphan signal transduction pathways, and methods of use
US6780642B2 (en) * 2000-08-04 2004-08-24 Florida Atlantic University Association of SIM2 with cancer
US20030190653A1 (en) * 2002-01-11 2003-10-09 Mehrdad Shamloo Regulated gene in the pathophysiology of ischemic stroke

Also Published As

Publication number Publication date
WO2002053735A1 (fr) 2002-07-11
US20060216705A1 (en) 2006-09-28
EP1354889B1 (de) 2008-04-23
DE60133774T2 (de) 2009-05-28
CA2433495A1 (en) 2002-07-11
EP1354951A1 (de) 2003-10-22
US7129065B2 (en) 2006-10-31
US7541189B2 (en) 2009-06-02
US20040248247A1 (en) 2004-12-09
CA2433501A1 (en) 2002-07-11
EP1354889A4 (de) 2004-12-29
CA2433495C (en) 2011-10-18
DE60133774D1 (de) 2008-06-05
ATE397664T1 (de) 2008-06-15
EP1354951B1 (de) 2008-06-04
CA2433492A1 (en) 2002-07-11
WO2002053736A1 (fr) 2002-07-11
EP1354946B1 (de) 2011-06-01
EP1354889A1 (de) 2003-10-22
EP1354946A1 (de) 2003-10-22
ATE393168T1 (de) 2008-05-15
CA2433501C (en) 2011-07-19
EP1354946A4 (de) 2005-01-05
US20040110171A1 (en) 2004-06-10
WO2002053729A1 (fr) 2002-07-11
EP1354951A4 (de) 2004-12-29
ATE511539T1 (de) 2011-06-15

Similar Documents

Publication Publication Date Title
ATE488588T1 (de) Verfahren zur kennzeichnung mesenchymaler stammzellen unter verwendung verschiedener marker
ES2170220T3 (es) Procedimiento para detectar sustancias biologicamente activas.
CA2403817A1 (en) Methods of modulating hair growth
EP1170380A3 (de) Zusammensetzungen und Verfahren zur Bestimmung antiviraler Wirkstoff Suszeptibilität und Resistenz sowie antivirales Wirkstoff-Screening
CA2267795A1 (en) Sample collection devices and methods using markers and the use of such markers as controls in sample validation, laboratory evaluation and/or accreditation
HK1062032A1 (en) Mediator stabilized reagent compositions and methods for their use in electrochemical analyte detection assays
DE60126006D1 (de) Sonde, Zelle und Verfahren zur Messung der Konzentration und der Zusammensetzung von Biomasse
ATE404867T1 (de) Verfahren und testbesteck zur beurteilung der oxidativen modifikation proteinhaltiger stoffe mittels messung ihrer antiradikalen aktivität
DE602007013068D1 (de) Verfahren zur untersuchung der reaktion auf eine behandlung mit einem monoklonalen antikörper
EP2094310B1 (de) Markergene zur verwendung bei der identifizierung von chondrozyten-phänotypischer stabilität und beim screenen von faktoren zur beeinflussung der knorpelproduktion
DE60134342D1 (de) Verfahren zur untersuchung der fähigkeit zur kontrolle der nervenzellplastizität
ATE333091T1 (de) Verfahren zur messung von blutersatzstoffen
ATE414701T1 (de) Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren
ATE350660T1 (de) Verfahren zur untersuchung der wirkung eines angionegesis-hemmers unter vermittlung durch hemmung der integrin-expression
ATE365326T1 (de) Verfahren zur analyse der menge an intraabdominalem fettgewebe
ATE412775T1 (de) Verfahren zur quantifizierung von nukleinsäuren mittels bestimmung der zellzahl
WO2009125936A3 (ko) 다낭성 난소 증후군 진단을 위한 분석방법 및 키트
DE602005008710D1 (de) Verfahren zur untersuchung der aktivität von ionenkanälen
Sesardic et al. Alternatives to the LD50 assay for botulinum toxin potency testing: Strategies and progress towards refinement, reduction and replacement
DE60133708D1 (de) Verfahren zur Analyse von Nicht-Protein Komponenten mittels Verwendung einer Protease aus einem Bacillus-Stamm
DE69938973D1 (de) Verfahren zur feststellung von einer thiol enthaltenden zusammensetzung
ATE421693T1 (de) Proteine in der diabetes-proteomanalyse
DE60322240D1 (de) Katzenpankreas-lipase-zusammensetzung und verfahren zur herstellung und verwendung einer solchen zusammensetzung
DE69635925D1 (de) Verfahren und testsatz zur evaluierung der metastasierungstendenz von tumoren
AU2001276569B2 (en) Quantitative fluorescent assay for determining the activity of transport proteins

Legal Events

Date Code Title Description
8364 No opposition during term of opposition